Your browser doesn't support javascript.
loading
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.
Dickson, Mark A; Schwartz, Gary K; Keohan, Mary Louise; D'Angelo, Sandra P; Gounder, Mrinal M; Chi, Ping; Antonescu, Cristina R; Landa, Jonathan; Qin, Li-Xuan; Crago, Aimee M; Singer, Samuel; Koff, Andrew; Tap, William D.
Afiliação
  • Dickson MA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Schwartz GK; Columbia University Medical Center, New York, New York.
  • Keohan ML; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • D'Angelo SP; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Gounder MM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Chi P; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Antonescu CR; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Landa J; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Qin LX; Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Crago AM; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Singer S; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
  • Koff A; Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Tap WD; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York8Weill Cornell Medical College, New York, New York.
JAMA Oncol ; 2(7): 937-40, 2016 Jul 01.
Article em En | MEDLINE | ID: mdl-27124835

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Inibidores de Proteínas Quinases / Relação Dose-Resposta a Droga / Lipossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Inibidores de Proteínas Quinases / Relação Dose-Resposta a Droga / Lipossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article